CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $83,000 | -1.2% | 14,351 | +21.1% | 0.01% | -14.3% |
| Q1 2021 | $84,000 | -1.2% | 11,851 | -18.8% | 0.01% | -12.5% |
| Q3 2020 | $85,000 | +9.0% | 14,591 | +25.9% | 0.01% | 0.0% |
| Q2 2020 | $78,000 | -10.3% | 11,591 | -14.8% | 0.01% | -33.3% |
| Q1 2020 | $87,000 | -56.9% | 13,601 | +205.9% | 0.01% | -40.0% |
| Q2 2018 | $202,000 | -47.1% | 4,446 | -38.5% | 0.02% | -50.0% |
| Q1 2018 | $382,000 | -12.0% | 7,226 | +13.3% | 0.04% | -28.6% |
| Q4 2017 | $434,000 | +7.4% | 6,376 | +30.1% | 0.06% | +5.7% |
| Q3 2017 | $404,000 | +2.0% | 4,900 | +16.0% | 0.05% | +1.9% |
| Q2 2017 | $396,000 | +76.8% | 4,225 | +19.9% | 0.05% | +79.3% |
| Q1 2017 | $224,000 | – | 3,525 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |